WILMINGTON, DE — Phreesia, Inc. (NYSE: PHR) has reported robust financial results for the fiscal fourth quarter and full year ...

Phreesia remains resilient, maintaining guidance and showing strong financial performance. Find out why I remain bullish on ...

Phreesia (NYSE:PHR) is up ~7% in Thursday trading after reporting fiscal 2024 Q4 financial results that beat on both lines ...

Phreesia, a leader in patient intake, outreach and activation, has been named to G2’s 2025 Best Software Awards in the Best ...

Phreesia (NYSE:PHR – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities research analysts at Needham & Company LLC in a research report issued on Thursday,Benzinga reports. They ...

Phreesia (NYSE:PHR – Free Report) had its price objective upped by Canaccord Genuity Group from $34.00 to $35.00 in a report issued on Thursday,Benzinga reports. They currently have a buy rating on ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, ...

First, I would like to introduce Balaji Gandhi, Phreesia's Chief Financial Officer. Mr. Gandhi, you may begin. Thank you, operator. Good evening, and welcome to Phreesia's earnings conference call ...

Truist Financial analyst Jailendra Singh maintained a Buy rating on Phreesia (PHR – Research Report) today. The company’s shares closed ...

In a report released today, Scott Schoenhaus from KeyBanc maintained a Buy rating on Phreesia (PHR – Research Report), with a price target of ...

Phreesia, a leader in patient intake, outreach and activation, has been named to G2’s 2025 Best Software Awards in the Best Healthcare Software Products category. As the world’s largest and ...